# Ritedose expands BFS capacity for ophthalmic and respiratory medications

The Ritedose Corporation is expanding its sterile Blow-Fill-Seal (BFS) production capabilities at its Columbia, SC facility, adding 180-million-unit dose capacity for ophthalmic and respiratory medications. The new equipment is expected to begin production in August 2024.

- Type: Expansion
- Announced: 2024-06-20
- Where: Columbia, South Carolina, United States
- Starts operating: Aug 2024
- Status: under construction
- Capacity: 180 million units per year
- Products: sterile blow-fill-seal unit dose ophthalmic and respiratory medications
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Ritedose Corp.](https://endata.com/companies/51334.md)

## Sources

- [prnewswire.com](https://www.prnewswire.com/news-releases/ritedose-the-leading-pharmaceutical-manufacturer-cdmo-specializing-in-sterile-blow-fill-seal-expands-its-bfs-capacity-to-meet-the-growing-demand-for-ophthalmic-and-respiratory-medications-302177567.html), 2024-06-20: "Ritedose has expanded its sterile Blow-Fill-Seal (BFS) capabilities, and the new equipment is expected to begin production in August of this year."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.